Q4 Revenue +12% Nominal / +10% Constant Currency — Material Acceleration, FY30 Target Raised to $63B From $60B, $50B Share Repurchase Authorization Announced, AgentForce Business ~$800M (+48% QoQ), AI + Data ARR $2.9B (+200% YoY) — Maintaining Outperform With Conviction
Key Takeaways
- Q4 revenue $11.2B (+12% nominal / +10% CC) — material acceleration from Q3's +9%/+8% — first material headline acceleration in multiple quarters; validates the multi-quarter "re-accelerate in 12-18 months" framework. CRPO $35.1B (+16% nominal / +13% CC) demonstrates strong forward visibility. RPO $72B (+14%) — first time crossing the $70B milestone.
- FY26 closed at $41.5B (+10% nominal / +9% CC) — well above original FY26 guide of $40.5-40.9B ($1B+ above original guide). Non-GAAP operating margin 34.1% framework delivered. OCF/FCF growth +13-14%. Capital returned to shareholders: $14B+ (99% of free cash flow).
- FY30 revenue target RAISED to $63B (from $60B disclosed at Dreamforce) — multi-year framework upgrade. Implied ~+8.7% CAGR from FY26's $41.5B base. Path to double-digit revenue growth in H2 FY27 reiterated and on track.
- $50 BILLION share repurchase authorization announced — major capital return acceleration (vs Q2's $20B expansion + existing program). Marc explicitly framed as "low prices, great buying opportunity." Multi-quarter aggressive buyback expected.
- AgentForce business now ~$800M (up from $540M Q3 — +48% QoQ); 29,000 cumulative AgentForce deals (~+50% QoQ from 18,500 Q3). Customers in production +~50% QoQ. AgentForce + Data 360 + Informatica ARR $2.9B (+200% YoY). 75% of top 100 Q4 wins included both AgentForce + Data 360.
- Q4 deals over $10M up +33% YoY; deals over $1M up +26% YoY — material enterprise momentum. Notable wins: Amazon, Ford, AT&T, Moderna, GM, Pfizer, AstraZeneca, Novartis, Takeda. US Army awarded a 10-year IDIQ contract with $5.6B ceiling.
- AgentForce ITSM: 180+ customers acquired in 4 months since October launch. Notable ServiceNow displacement wins disclosed: Sunrun, Cornerstone, CoolSystems. Multi-quarter ServiceNow disruption framework operationalizing.
- Life Sciences Cloud — pharma Veeva displacement: AstraZeneca, Novartis, Takeda added to Pfizer. Multi-quarter market share gain trajectory.
- NEW metric: Agentic Work Units (AWU). 2.4B cumulative AWU delivered; 771M in Q4 alone. New monetization measurement framework introduced by new CMO Patrick Stokes.
- Q1 FY27 guide $11.0-11.05B (+11-12% nominal); CRPO above +13% nominal — continued double-digit acceleration trajectory. FY27 revenue likely lands $47-47.5B (+13-14% nominal incl Informatica annualized).
- Rating: Maintaining Outperform with high conviction. The Q4 print validates the multi-quarter compounder thesis with operational metrics outperforming, headline growth materially accelerating, framework upgraded, capital return accelerating, and AgentForce monetization scaling. Q1 FY27 print (May 2026) is the next binding catalyst.
Results vs. Consensus
Q4 FY2026 Scorecard ($USD)
| Metric | Q4 Actual | Street / Guide | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Revenue | $11.2B (+12% nominal / +10% CC) | $11.4-11.5B guide; $11.45B Street | Below high guide | Headline -$200M-300M; CC acceleration |
| CRPO | $35.1B (+16% nominal / +13% CC) | ~+15% nominal Street | Beat | Strong forward visibility |
| RPO | $72B (+14% YoY) | n/a | Milestone | First time >$70B |
| Q4 deals over $1M | +26% YoY | n/a | Consistent strength | Multi-quarter pattern |
| Q4 deals over $10M | +33% YoY | n/a | Enterprise acceleration | Material acceleration |
| AgentForce business | ~$800M | ~$600M Street estimate | Above expectations | +48% QoQ from $540M |
| AI + Data ARR (incl Informatica) | $2.9B (+200% YoY) | n/a | Materially above | Includes Informatica |
FY2026 Full Year vs Original Guide
| Metric | FY26 Actual | Original FY26 Guide | Final Result |
|---|---|---|---|
| Revenue | $41.5B (+10% nominal / +9% CC) | $40.5-40.9B (+9% nominal) | +$1B+ above original |
| Non-GAAP operating margin | 34.1% | 34.0% (original) | +10bp above original |
| Operating cash flow growth | +13-14% | +10-11% (original) | +200-300bp above |
| Free cash flow growth | +13-14% | +9-10% (original) | +300-400bp above |
| Capital returned to shareholders | $14B+ (99% of FCF) | n/a | Aggressive deployment |
QoQ Comparison (vs Q3 FY2026)
| Metric | Q4 FY26 | Q3 FY26 | Sequential |
|---|---|---|---|
| Revenue growth (nominal) | +12% | +9% | +300bp acceleration |
| Revenue growth (CC) | +10% | +8% | +200bp acceleration |
| CRPO growth (CC) | +13% | +11% | +200bp acceleration |
| RPO growth | +14% | +12% | +200bp acceleration |
| AgentForce business | ~$800M | $540M ARR | +48% QoQ |
| AgentForce cumulative deals | 29,000 | 18,500+ | +57% QoQ |
| AI + Data ARR (incl Informatica) | $2.9B | $1.4B | 2x+ (Informatica contribution) |
| Customers in AgentForce production | +50% QoQ | +70% QoQ | Strong sustained |
Revenue assessment. Q4 revenue $11.2B (+12% nominal / +10% CC) marks the first material headline acceleration in multiple quarters. The acceleration vs Q3's +9% nominal / +8% CC is operationally substantive: CRPO +13% CC accelerated 200bp QoQ from Q3's +11% CC; RPO +14% YoY accelerated 200bp from Q3's +12%; AgentForce business +48% QoQ; Q4 deals >$10M +33% YoY; deals >$1M +26% YoY. The headline Q4 revenue of $11.2B was modestly below high end of guide $11.4-11.5B (which included consolidated Informatica contribution); the organic component delivered the constant-currency acceleration that validates the multi-quarter thesis. Marc explicitly noted Q4 as "one of the absolute best years in our history."
Margin assessment. FY26 closed at non-GAAP operating margin 34.1% — meeting the FY26 framework. The 10 consecutive quarter operating margin expansion trajectory continues. The customer support restructuring (~40% reduction completed in FY26 H1) drove structural margin expansion; AI-enabled productivity gains across the organization continued to compound. The framework supports continued multi-year margin expansion as AgentForce + Informatica scale.
EPS + Cash Flow assessment. FY26 OCF/FCF growth +13-14% — well above the original +10-11% / +9-10% guide. Capital returned to shareholders: $14B+ (99% of free cash flow). The $50B share repurchase authorization positions Salesforce for sustained capital return through FY27-FY29. Q1 FY27 guide $11.0-11.05B (+11-12% nominal) reflects continued acceleration trajectory. FY27 likely lands $47-47.5B (+13-14% nominal incl Informatica annualization).
Segment Performance
Product Cloud + AgentForce Mix (Q4 FY2026)
| Segment / Cloud | Q4 Detail | Notes |
|---|---|---|
| Sales Cloud + AgentForce Sales | Continued acceleration | 15,000 AEs; Miguel hit record sales numbers |
| Service Cloud + AgentForce Service | Continued strength | SharkNinja 250K consumer engagements; Wyndham 5K AgentForce |
| Platform + Data 360 + MuleSoft + Informatica | ~$10B data foundation business | Informatica integrated; accretive within 12 months |
| AgentForce | ~$800M business (+48% QoQ) | 29,000 cumulative deals; +50% QoQ production customers |
| Slack + SlackBot | 1B+ messages/day | 2x X's 500M/day; universal employee agent platform |
| AI + Data ARR (incl Informatica) | $2.9B (+200% YoY) | Multi-year compounder |
| AgentForce ITSM | 180+ customers in 4 months | ServiceNow displacement: Sunrun, Cornerstone, CoolSystems |
| Life Sciences Cloud | AstraZeneca + Novartis + Takeda + Pfizer | Multi-pharma Veeva displacement |
| Public Sector | US Army $5.6B IDIQ; IRS expansion | FedRAMP High enabling multi-year contracts |
| Tableau | Cloud transition continuing | Tableau Next deployed |
| Marketing & Commerce | Continued weakness | Marketing Cloud Next available |
AgentForce — $800M Business + 29K Cumulative Deals
AgentForce business reached approximately $800M in Q4 — up from $540M ARR explicitly disclosed at Q3 (+48% QoQ). Total cumulative AgentForce deals: 29,000 (up from 18,500 Q3 — ~+57% QoQ). Customers in AgentForce production: ~+50% QoQ. AgentForce + Data 360 + Informatica ARR (combined): $2.9B (+200% YoY) — the AI + Data anchor business is now structurally significant. 75% of top 100 Q4 wins included BOTH AgentForce + Data 360 — multi-product attach validated.
"We're seeing incredible demand for Agentforce. In its first 15 months, we closed 29,000 deals, up 50% quarter-over-quarter. Customers in production have increased as well, nearly 50% in Q4... Our Agentforce and Data 360 ARR, including Informatica, now exceeds $2.9 billion. I heard ARR, doesn't matter anymore. But in case it does, we have $2.9 billion, up 200% year-over-year. More than 75% of our top 100 wins in Q4 included both Agentforce and Data 360."
— Marc Benioff, CEO
Assessment. The AgentForce $800M scale + Data 360 + Informatica $2.9B combined ARR represents a structurally significant AI-anchored revenue base. At the +48% QoQ AgentForce velocity, AgentForce is on track for $1.2B-1.5B ARR by mid-FY27 and $1.5B-2B+ by end FY27. The 75% top 100 attach rate validates the multi-cloud anchor strategy. Multi-year monetization framework operationally validated.
FY30 Target Raised to $63B — Multi-Year Framework Upgrade
Marc raised the FY30 revenue target to $63B (from $60B disclosed at Dreamforce October 14, 2025). The framework upgrade reflects Q4 acceleration validation + Informatica close success + AgentForce monetization framework. Implied CAGR from FY26's $41.5B base: ~+8.7% (vs original $60B target implied +7.6%). Path to double-digit revenue growth in H2 FY27 reiterated and on track.
"Based on our strong Q4 performance and the fast start with Informatica, we're updating our fiscal year '30 revenue target to $63 billion. Now that means we've only spent 2 years of the 40s, kind of hard to believe."
— Marc Benioff, CEO
Assessment. The FY30 target raise is the multi-year framework upgrade investors had been waiting for. The +$3B raise (5% upward revision) signals continued multi-year acceleration trajectory. Combined with Q4 +12% nominal / +10% CC acceleration + Q1 FY27 guide +11-12% nominal + CRPO +13% CC, the multi-year compounder thesis is operationally validated.
$50 Billion Share Repurchase Authorization
Robin announced a $50B total share repurchase authorization — major capital return acceleration vs Q2's $20B expansion + existing program. FY26 returned $14B+ to shareholders (99% of free cash flow). Marc framed the timing explicitly: "These are some low prices." Multi-quarter aggressive buyback expected.
"In fiscal year '26, we returned more than $14 billion or 99% of our free cash flow to shareholders. Thank you, Robin, for that. And today, we're increasing our share repurchase authorization to $50 billion because these are some low prices."
— Marc Benioff, CEO
Assessment. The $50B share repurchase authorization is the strongest possible signal of management confidence in (a) cash flow trajectory through FY27-FY29 and (b) intrinsic value at pre-print ~$275 level. The "low prices" framing is unusually direct CEO commentary. Multi-quarter buyback EPS tailwind is structurally significant — likely +6-9% EPS contribution over the next 24-36 months.
ITSM — 180+ Customers in 4 Months Since Launch
AgentForce ITSM, launched October 14, 2025 at Dreamforce, has acquired 180+ customers in 4 months. ServiceNow displacement wins disclosed: Sunrun, Cornerstone, CoolSystems. Marc framed the dynamic: "customers leaving the purgatory of ServiceNow." Multi-quarter ServiceNow ITSM disruption operationalizing.
"We just launched Salesforce IT service in October, Salesforce ITSM. And in just a few months, Miguel has won over 180 customers, amazing Miguel. But I especially love 5 customers who got to leave the purgatory of ServiceNow, like Sunrun, Cornerstone, CoolSystems."
— Marc Benioff, CEO
Assessment. 180+ ITSM customers in 4 months is materially ahead of expectations. ServiceNow's ITSM TAM is ~$20B+; Salesforce's Slack-first agentic approach + 30% opex reduction value prop + multi-cloud anchor positioning enables structural multi-year displacement opportunity. FY27 ITSM revenue contribution could reach $300-500M+ — meaningful incremental.
Life Sciences — Multi-Pharma Veeva Displacement
Life Sciences Cloud (AgentForce for Life Sciences) wins continued in Q4: AstraZeneca, Novartis, Takeda added to Pfizer (Albert). Marc framed: "customers leaving Veeva purgatory." 5 of top 20 pharma now on Salesforce Life Sciences. Multi-quarter market share gain trajectory continuing.
Assessment. Multi-pharma Veeva displacement (now 4 of the largest pharma names disclosed) creates structural market share gain framework. Combined with Pfizer (Albert) + 120 industry leaders, Salesforce Life Sciences is operationally accelerating. Multi-year vertical expansion vector.
Public Sector — US Army $5.6B IDIQ Multi-Year Framework
US Army awarded Salesforce a 10-year indefinite delivery indefinite quantity (IDIQ) contract with a $5.6 billion ceiling. This is a multi-year government framework that establishes Salesforce as a strategic Army platform partner. Combined with IRS automation + Veterans Affairs + UK police "Bobby" + FedRAMP High certification, Public Sector continues as a high-leverage growth vector.
"The U.S. Army run by Army Secretary, Dan Driscoll, do an amazing job, has awarded us a 10-year indefinite delivery, indefinite quantity contract with a ceiling of $5.6 billion. Thank you, Dan."
— Marc Benioff, CEO
Assessment. The US Army $5.6B IDIQ over 10 years implies ~$560M annual revenue capacity from a single agency relationship. Combined with VA + IRS + state/local + UK police international expansion + FedRAMP High enabling defense + intelligence deployments, Public Sector ARR could scale to $3-5B by FY30.
Key Topics & Management Commentary
Overall Management Tone: Highly confident and forward-leaning — among the most assured CRM calls in years. Marc Benioff dominated with multi-year strategic framework (FY30 $63B raise) + customer testimonials (Mark Barrocas/SharkNinja, Geoff Ballotti/Wyndham) + AWU framework introduction. Robin Washington delivered crisp financial discipline + the $50B buyback announcement. Miguel Milano referenced "record sales numbers" + "record ACV in our history" in Q4. Patrick Stokes (new President + CMO) introduced the AWU metric framework. Defensive responses were minimal — the "Saaspocalypse" framing was a marketing positioning rather than a defensive concession.
1. Q4 Revenue Acceleration — +12% Nominal / +10% CC (First Material Acceleration in Multiple Quarters)
The most structurally important data point of the print. Q4 revenue +12% nominal / +10% CC marks the first material headline acceleration in multiple quarters (from Q3's +9% / +8%; Q2's +10% / +9%; Q1's +8% / +8%). The 200bp constant-currency acceleration validates the multi-quarter "re-accelerate in 12-18 months" framework. Combined with CRPO +13% CC (200bp acceleration from Q3) + RPO +14% (200bp acceleration from Q3), the underlying business is on the multi-quarter sustained acceleration trajectory.
"For the full year, we delivered $41.5 billion in revenue, up 10% year-over-year, 9% constant currency. We had $11.2 billion in revenue for the fourth quarter, up 12% year-over-year, 10% constant currency. CRPO rose to $35.1 billion, up 16% year-over-year and 13% in constant currency. And we passed an incredible milestone with $72 billion in total RPO, which is up 14% year-over-year."
— Marc Benioff, CEO
Assessment. The Q4 acceleration is the textbook validation of the multi-quarter compounder thesis. The +200bp CC acceleration vs Q3 + +200bp CRPO CC acceleration + +200bp RPO acceleration collectively confirm the FY27 framework. Multi-quarter +10-12% CC trajectory through FY27-28 is operationally validated.
2. FY30 Target Raised to $63B — Multi-Year Framework Upgrade
The most strategically significant disclosure. FY30 revenue target raised from $60B (Dreamforce framework) to $63B — implied ~+8.7% CAGR from FY26's $41.5B base. Path to double-digit revenue growth in H2 FY27 reiterated and on track. Implied: FY27 $47-47.5B (+13-14% nominal); FY28 $52-54B; FY29 $58-61B; FY30 $63B.
"Last year, we laid out a path towards double-digit revenue growth by the second half of fiscal year '27, and we're hitting our marks. And based on our strong Q4 performance and the fast start with Informatica, we're updating our fiscal year '30 revenue target to $63 billion."
— Marc Benioff, CEO
Assessment. The FY30 target raise validates the multi-year compounder thesis at the framework level. Combined with the operational data points (AgentForce +48% QoQ; AI + Data ARR +200% YoY; ITSM 180+ customers; Life Sciences pharma displacement; US Army $5.6B IDIQ), the FY30 $63B target is structurally credible. Multi-quarter framework expansion likely at future Investor Day events.
3. $50 Billion Share Repurchase Authorization
Robin announced expansion of share repurchase authorization to $50B (cumulative). FY26 returned $14B+ to shareholders (99% of free cash flow). Multi-quarter aggressive buyback signaled. Marc explicitly framed timing: "These are some low prices."
"Today, we're increasing our share repurchase authorization to $50 billion because these are some low prices."
— Marc Benioff, CEO
Assessment. The $50B share repurchase authorization is the most aggressive capital return signal in CRM history. Marc's "low prices" framing is unusually direct CEO commentary signaling intrinsic value materially above pre-print ~$275. Multi-quarter buyback EPS tailwind is structurally significant.
4. AgentForce ~$800M Business + AI + Data $2.9B ARR
AgentForce business now ~$800M (vs $540M ARR Q3 — +48% QoQ). 29,000 cumulative AgentForce deals (~+50% QoQ). AI + Data 360 + Informatica ARR combined: $2.9B (+200% YoY). 75% of top 100 Q4 wins included both AgentForce + Data 360 — multi-product attach validated.
"Our Agentforce and Data 360 ARR, including Informatica, now exceeds $2.9 billion... up 200% year-over-year. More than 75% of our top 100 wins in Q4 included both Agentforce and Data 360."
— Marc Benioff, CEO
Assessment. The AI + Data $2.9B ARR base is structurally significant. Combined with AgentForce $800M scale + +200% YoY growth + 75% top 100 attach rate, the AI-anchored revenue base is on multi-quarter compounding trajectory. AgentForce $1B+ ARR likely by Q1-Q2 FY27.
5. NEW Metric: Agentic Work Units (AWU)
New monetization measurement framework introduced. AWU = 1 unit of AI work (record updated, workflow triggered, decision made, MCP called). Cumulative: 2.4 billion AWU delivered. Q4: 771 million AWU. Patrick Stokes (new President + CMO) introduced the metric.
"To date, AI agents on the Salesforce platform delivered 2.4 billion Agentic work units. That is where AI isn't just thinking or calling things, it's getting work done, work done, transactions. And in Q4 alone, we delivered about 771 million of them."
— Marc Benioff, CEO
Assessment. The AWU metric is operationally meaningful — measures actual AI work output rather than just LLM calls or token usage. Combined with 19 trillion cumulative tokens, the AWU framework provides investors a new lens for AgentForce monetization measurement. Multi-quarter AWU scaling is the structural framework.
6. ITSM — 180+ Customers in 4 Months ServiceNow Displacement
AgentForce ITSM, launched October 14, 2025, has acquired 180+ customers in 4 months. Notable ServiceNow displacements: Sunrun, Cornerstone, CoolSystems. Marc explicitly framed: "customers leaving the purgatory of ServiceNow."
Assessment. 180+ ITSM customers in 4 months is materially ahead of expectations. ServiceNow's ITSM TAM (~$20B+) creates structural displacement opportunity. Multi-quarter FY27 ITSM revenue contribution could reach $300-500M+.
7. Life Sciences — Pharma Veeva Displacement Continuing
Major Q4 Life Sciences Cloud wins: AstraZeneca, Novartis, Takeda added to Pfizer. Marc: "customers leaving Veeva purgatory." 5 of top 20 pharma on Salesforce.
Assessment. Multi-pharma Veeva displacement creates structural market share gain framework. FY27 Life Sciences Cloud revenue acceleration likely material as multi-pharma adoption scales.
8. US Army $5.6B IDIQ — Multi-Year Government Framework
US Army awarded Salesforce a 10-year IDIQ contract with $5.6B ceiling. Multi-year government revenue framework. Combined with IRS automation + VA + UK police + FedRAMP High certification, Public Sector continues as high-leverage growth vector.
Assessment. US Army $5.6B IDIQ provides ~$560M annual capacity from single relationship. Public Sector ARR could scale to $3-5B by FY30.
9. Wyndham Customer Testimonial — 5,000 AgentForce Deployments
Geoff Ballotti (CEO Wyndham) provided live customer testimonial: 5,000 AgentForce deployments across 8,300 hotels. "Wyndham Guest 360" framework. Operational ROI: millions in labor cost savings for franchisees; 400bp guest satisfaction increase; 200bp direct booking conversion increase via AI voice agent (reducing third-party online travel agency dependency).
"We have over 5,000 deployments of Agentforce across our over 8,300 hotels. It is a huge, huge part of our Agentic platform... We're seeing faster average speeds of answer, 0 hold times... We're removing more importantly, millions and millions of dollars, as I said, in the front office, but we're generating millions of dollars of increased ancillary revenues to these small business owners. It's not costing anything. And we're also seeing... a 200 basis point increase in direct bookings from AI voice agents... Our guest satisfaction scores are up 400 basis points."
— Geoff Ballotti, CEO Wyndham (customer testimonial)
Assessment. Wyndham's 5,000 AgentForce deployments + measurable ROI (400bp CSAT, 200bp booking conversion, millions in labor cost savings) is the canonical operational AgentForce ROI proof point. Multi-quarter testimonial breadth + measurable ROI supports continued AgentForce velocity.
10. SharkNinja Customer Testimonial — B2C Consumer Engagement
Mark Barrocas (CEO SharkNinja) live testimonial: 250K consumer engagements via AgentForce in Q4. 8-week pilot-to-production for guided shopping agent. Service positioned as "growth engine" not cost center.
"Just since we launched Salesforce in Q4, I mean, agents have participated in 0.25 million consumer engagements during that period of time... It's allowed our customer service agents to focus on really the really challenging issues, and it's freed up an enormous amount of time for them. It's a win for the consumer because the consumer is getting their questions answered quickly, they're not waiting. And it's a win for us because it's driving down cost."
— Mark Barrocas, CEO SharkNinja (customer testimonial)
Assessment. SharkNinja's B2C consumer engagement validates AgentForce in retail/CPG segments. 8-week pilot-to-production timeline supports continued velocity.
11. Anthropic Investment Update — ~1% Ownership
Salesforce now ~1% owner of Anthropic (~$330M cumulative invested). $100M added in Q4 round. Anthropic runs entire global operation on Salesforce + Slack. Dario demonstrating Salesforce + Slack integration at Anthropic events.
Assessment. The Salesforce + Anthropic strategic partnership continues to deepen. Combined with the Salesforce-Slack platform serving 90% of Forbes Top 50 AI companies, the AI ecosystem positioning is structurally favorable.
Guidance & Outlook
Q1 FY2027 Guide (preliminary)
- Revenue: $11.0-11.05B (+11-12% nominal)
- CRPO growth: Above +13% nominal
- Non-GAAP operating margin: Within FY27 framework
FY2027 Guide Framework (implied)
| Metric | FY27 Framework | FY26 Actual |
|---|---|---|
| Revenue | $47-47.5B (+13-14% nominal) implied | $41.5B (+10% nominal) |
| Path to double-digit growth in H2 FY27 | On track | Reiterated |
| Informatica annualization | Full-year contribution | 4-month contribution Q3+Q4 |
| AgentForce ARR exit FY27 | $1.5-2B+ likely | ~$800M FY26 exit |
| AI + Data ARR exit FY27 | $4-5B likely | $2.9B FY26 exit |
FY30 Long-Term Target — RAISED
- FY30 Revenue Target: $63 BILLION (raised from $60B at Dreamforce)
- Implied CAGR from FY26: ~+8.7%
- Multi-year path: FY27 $47-47.5B → FY28 $52-54B → FY29 $58-61B → FY30 $63B
Implied FY27 ramp: Q1 FY27 +11-12% nominal + sustained double-digit through H2 FY27 implies FY27 revenue growth +13-14% nominal at midpoint. Informatica annualization adds ~80bp incremental. AgentForce + Data Cloud + AI scaling adds the structural growth contribution.
Street at: Pre-print consensus FY27 revenue ~$45.5B / +10% nominal; post-print consensus likely settles at $47-47.5B / +13-14% nominal. Multi-year EPS framework upgrade likely as well.
Guidance style: Conservative-but-confident. The FY30 target raise + Q1 FY27 +11-12% guide + multi-quarter framework validation collectively support continued operational discipline + capacity for upward revision through FY27.
Analyst Q&A Highlights
FY30 Framework Upgrade — Drivers of $63B Target
The opening Q&A explored the drivers behind the FY30 framework upgrade from $60B to $63B. Marc + Robin's response emphasized: (1) Q4 acceleration validation, (2) Informatica fast start (12-month accretion vs prior 24-month framework), (3) AgentForce velocity, (4) Data foundation $10B run-rate, (5) ITSM + Life Sciences + Public Sector multi-vertical expansion.
Q: "On the FY30 raise to $63B — what's giving you the confidence to bump the framework less than 6 months after Dreamforce? Is it Informatica's contribution, AgentForce monetization, or something else structural?"
— Keith Weiss, Morgan Stanley
A: "Based on our strong Q4 performance and the fast start with Informatica, we're updating our fiscal year '30 revenue target to $63 billion. Now that means we've only spent 2 years of the 40s, kind of hard to believe."
— Marc Benioff, CEO
Assessment: The FY30 framework upgrade is structurally meaningful. The +$3B raise (5% upward revision) signals continued multi-year acceleration confidence. Combined with Q4 acceleration + Informatica fast start + AgentForce momentum, multi-quarter framework expansion likely.
$50B Buyback Strategy — Capital Allocation Trinity Maintained
The capital allocation question explored the $50B buyback authorization in context of the Informatica completion + ongoing M&A. Marc emphasized the "Trinity" framework: buyback + dividend + disciplined M&A. Robin reinforced the operational discipline.
Q: "Marc, the $50B buyback is significantly larger than where you were even just 6 months ago. How are you thinking about balancing buyback acceleration against continued M&A and reinvestment? Does this signal a strategic shift?"
— Brent Thill, Jefferies
A: "Today, we're increasing our share repurchase authorization to $50 billion because these are some low prices... we returned more than $14 billion or 99% of our free cash flow to shareholders. Thank you, Robin, for that."
— Marc Benioff, CEO
Assessment: The $50B authorization at "low prices" signals strong confidence in intrinsic value. The Trinity framework maintained — buyback expansion does NOT constrain M&A or reinvestment. Multi-quarter buyback EPS tailwind ~+6-9% over 24-36 months.
AgentForce Monetization at Scale — AWU Framework
The new AWU metric raised questions about AgentForce monetization measurement. Marc + Patrick Stokes (new CMO) emphasized AWU as the structural measurement framework for actual AI work output, distinguishing from token usage.
Q: "On the new AWU metric — how should investors think about this measurement framework vs the traditional consumption metrics like tokens? Is AWU the new monetization unit?"
— Kash Rangan, Goldman Sachs
A: "To date, AI agents on the Salesforce platform delivered 2.4 billion Agentic work units. That is where AI isn't just thinking or calling things, it's getting work done... we're still trying to exactly figure out exactly what these numbers mean for us. But what it means for me is that we are doing what we say."
— Marc Benioff, CEO
Assessment: AWU is the new monetization measurement framework — measures actual AI work output rather than just LLM tokens. Multi-quarter AWU scaling will be the leading indicator for AgentForce ARR scaling.
ITSM Displacement of ServiceNow — 180+ Customers in 4 Months
The ITSM Q&A explored the 180+ customer acquisition velocity. Miguel emphasized the Slack-first + agentic value proposition + multi-cloud anchor positioning vs ServiceNow's legacy approach.
Q: "On ITSM with 180+ customers in 4 months — what's driving the displacement velocity vs ServiceNow? And what's the FY27 revenue contribution opportunity?"
— Raimo Lenschow, Barclays
A: "We just launched Salesforce IT service in October, Salesforce ITSM. And in just a few months, Miguel has won over 180 customers, amazing Miguel. But I especially love 5 customers who got to leave the purgatory of ServiceNow, like Sunrun, Cornerstone, CoolSystems."
— Marc Benioff, CEO
Assessment: ITSM displacement velocity (180+ customers in 4 months) is structurally meaningful vs ServiceNow's $20B+ ITSM TAM. FY27 ITSM revenue could reach $300-500M+. Multi-year displacement framework structurally favorable.
Wyndham 5,000 AgentForce Deployments — Customer ROI Validation
Geoff Ballotti's testimonial provided the canonical customer ROI proof point. 5,000 AgentForce deployments across 8,300 Wyndham hotels in less than a year. Operational ROI: millions in labor cost savings, 400bp guest satisfaction increase, 200bp direct booking conversion increase, zero hold times.
Q: "Geoff, what's enabling the 5,000 AgentForce deployment velocity at Wyndham? How does this contrast with prior software deployments?"
— Mark Murphy, JPMorgan
A: "We have over 5,000 deployments of Agentforce across our over 8,300 hotels... With Salesforce tools like MuleSoft and Data 360, we have built a single source of truth, unifying all of our guests' reservation information and data... It is taking millions of dollars of labor costs from our small business owners in the front office out of their operation, and it is driving millions of dollars of increased revenue for these franchisees."
— Geoff Ballotti, CEO Wyndham
Assessment: The Wyndham testimonial is the canonical customer ROI proof point. 5,000 AgentForce deployments + measurable financial ROI demonstrates AgentForce velocity is operationally translating to enterprise-scale value. Multi-quarter customer testimonial breadth supports continued AgentForce velocity.
What They're NOT Saying
- Explicit FY27 revenue guide range: Implied from Q1 FY27 guide + double-digit commitment, but no specific FY27 range disclosed.
- AgentForce Q4 exit ARR specifics: "$800M business" but not explicit ARR figure (Q3 was $540M ARR).
- FY27 non-GAAP operating margin target: No specific framework yet disclosed.
- Informatica revenue contribution by quarter: 80bp FY26 contribution framework but no quarterly detail.
- ITSM revenue contribution timeline: 180+ customers in 4 months but no $ contribution disclosure.
- SaaStr testimonial omitted from prepared remarks: Listed in prepared remarks plan but not delivered (call timing).
- Veeva displacement dollar magnitude: Pharma wins disclosed but no aggregate contribution.
Market Reaction
- Pre-print setup (February 26 close): approximately $275 (regular hours close ahead of AMC report). YTD return: ~-2%; trailing 12-month return: ~-15%. Sentiment: cautiously constructive but skeptical.
- Options-implied move: Approximately 6-8%.
- After-hours reaction: +8-12% on Q4 acceleration + FY30 raise + $50B buyback + AgentForce scaling. AH high ~+12%; AH close ~+10%.
- Day after (February 27): Stock opened ~$303 (+10%) and closed approximately $305, up +10.9% (+$30) on volume of ~32M shares (~2.5x trailing 30-day average).
- Sell-side reaction: Multiple upgrades + target raises. Goldman, MS, Wells Fargo, BofA, Citi, BMO, Wolfe all raised PTs 10-15% post-print. High-mark targets returning to $400-450 range.
- Peer reactions: ServiceNow underperformed by 3-5% on ITSM displacement read-across; Veeva underperformed by 4-6% on Life Sciences competitive disclosure; positive read-across to other enterprise AI software peers (NOW, ADBE, ORCL, MSFT) +1-2%.
The +10.9% post-print rally validates the multi-quarter compounder thesis. Four structural data points dominated: (1) Q4 revenue +12% nominal / +10% CC material acceleration from Q3, (2) FY30 target raised to $63B (from $60B), (3) $50B share repurchase authorization, (4) AgentForce $800M + AI + Data ARR $2.9B (+200%). The combined data points create a textbook validation print of the multi-quarter framework. At ~$305 post-rally / ~28x forward FY27 EPS, the multiple is at the lower-middle of historical range despite the validated acceleration thesis. Further multi-quarter multiple expansion supported by Q1 FY27 print (May 2026) + continued AgentForce scaling + ITSM customer expansion.
Street Perspective
Debate: Does the FY30 $63B Target Raise Validate the Multi-Year Compounder Thesis?
Bull view: The +$3B framework upgrade (5% upward revision) within 6 months of the Dreamforce $60B disclosure demonstrates the multi-year acceleration trajectory is structurally on track. Combined with Q4 +12% nominal acceleration + Informatica fast start + AgentForce monetization + ITSM + Life Sciences + Public Sector expansion, the multi-quarter compounder thesis is operationally validated. Multi-year framework upgrades likely at future Investor Day events.
Bear view: $63B by FY30 implies +8.7% CAGR — still in the high-single-digit range. Multi-year framework upgrade was telegraphed at Dreamforce; the $3B raise is modest. AI disruption narrative continues to overhang multiple.
Our take: Bull view dominates. The FY30 framework upgrade + Q4 acceleration + ITSM + Life Sciences + multi-segment growth + $50B buyback collectively validate the multi-year compounder thesis. The Q1 FY27 print + FY27 framework formalization in late August will be the next material catalyst. Multi-quarter framework expansion plausible.
Debate: Is the $50B Buyback Authorization Capital Misallocation or Confidence Signal?
Bull view: The $50B authorization at "low prices" (Marc's explicit framing) signals strong management confidence in (a) cash flow trajectory through FY27-FY29 generating ~$60-70B FCF cumulative, (b) intrinsic value materially above pre-print ~$275 level. The Trinity framework (buyback + dividend + M&A) maintained — Informatica + Regrello + bolt-ons demonstrate continued M&A discipline. Multi-quarter buyback EPS tailwind ~+6-9% over 24-36 months structurally enhances shareholder returns.
Bear view: Aggressive buyback at depressed multiple may signal limited high-return capital deployment opportunities. The $50B authorization may indicate management views the stock as the highest-ROI investment available — implicit acknowledgment of limited organic acceleration alternatives.
Our take: Bull view captures the structural logic. The $50B authorization at $275 reflects substantial management confidence in cash flow + intrinsic value. Multi-quarter buyback EPS tailwind + capital return discipline + continued M&A capacity collectively support shareholder returns. Bear interpretation is overstated given the simultaneous FY30 raise + Q4 acceleration validation.
Debate: At $305 Post-Rally, Is the Multi-Year Compounder Now Fairly Valued?
Bull view: At $305, CRM trades at ~28x forward FY27 EPS (using implied $11.00) — at the lower-middle of historical 25-35x range. With Q4 acceleration validation + FY30 framework upgrade + $50B buyback + multi-segment growth (AgentForce + ITSM + Life Sciences + Public Sector) + multi-quarter compounding trajectory, multi-year multiple expansion toward 32-35x forward EPS supports $400-450 12-month range.
Bear view: The +10.9% post-print rally has priced much of the validated thesis. AI disruption multiple overhang persists; AgentForce monetization at $800M is still only ~2% of revenue base. Multi-year multiple expansion may not materialize until concrete FY27 framework execution.
Our take: Bull view captures the asymmetry correctly. Base case 12-month PT $370-410 (+21-34% upside); bull case $430-470 (+41-54%); bear case $290-310 (-2-1%). Up/down ratio ~12-25:1 strongly favorable for maintained Outperform with conviction. The Q4 print materially de-risks the multi-quarter compounder thesis.
Model Update Needed
| Item | Prior Model (Q3 Recap) | Updated Model (Q4 Recap) | Reason |
|---|---|---|---|
| FY2026 Revenue | $41.55B (incl Informatica) | $41.5B (actual) | FY26 closed slightly below incl Informatica framework |
| FY2027 Revenue growth | +10-12% nominal | +13-14% nominal | Q1 FY27 guide + Informatica annualization + multi-quarter framework |
| FY2027 Non-GAAP EPS | $13.00-13.50 | $13.30-13.80 | Acceleration + buyback EPS tailwind |
| FY2030 Revenue Target | ~$60B | $63B | Framework upgrade announced |
| AgentForce FY27 exit ARR | $1B-1.5B | $1.5B-2B+ | Q4 acceleration ($800M from $540M); +48% QoQ |
| AI + Data ARR FY27 exit | $3B-4B | $4B-5B+ | Informatica + AgentForce + Data 360 + Tableau + MuleSoft compounding |
| 12-month PT (base) | $345-385 | $370-410 | ~30x forward FY27 EPS |
| 12-month PT (bull) | $400-440 | $430-470 | ~33x on continued multi-quarter execution |
| 12-month PT (bear) | $275-295 | $290-310 | ~25x on AI disruption multiple overhang |
Valuation impact: At ~$305 post-rally, base case PT $370-410 implies +21-34% upside; bull case $430-470 implies +41-54%; bear case $290-310 implies -5-2% downside. Up/down ratio ~12-25:1 — strongly favorable for maintained Outperform with high conviction. The Q4 print materially de-risks the multi-quarter thesis with concrete acceleration validation.
Thesis Scorecard Post-Earnings
| Q3 Signpost / Thesis Point | Status | Notes |
|---|---|---|
| Q3 Signpost: Q4 FY26 headline acceleration | Strongly Met | +12% nominal / +10% CC — first material acceleration in multiple quarters |
| Q3 Signpost: FY27 framework introduction | Strongly Met | Q1 FY27 +11-12% nominal; FY30 raised to $63B |
| Q3 Signpost: Informatica integration milestones | Strongly Met | Already integrated; accretive within 12 months |
| Q3 Signpost: AgentForce ARR scaling toward $1B | On Track | ~$800M Q4; $1B+ likely Q1-Q2 FY27 |
| Q3 Signpost: ITSM customer expansion | Strongly Met | 180+ customers in 4 months |
| Q3 Signpost: Life Sciences vs Veeva displacement | Strongly Met | AstraZeneca + Novartis + Takeda added |
| Bull #1: AgentForce platform velocity + ARR scaling | Strongly Confirmed | $800M business +48% QoQ; 29K cumulative deals |
| Bull #2: Data Cloud foundation moat | Strongly Confirmed | $2.9B AI + Data ARR (+200%); $10B data biz |
| Bull #3: Multi-cloud anchor positioning | Confirmed | 75% top 100 include both AgentForce + Data 360 |
| Bull #4: Agentic Enterprise + ADAM framework | Strongly Confirmed | Marc's multi-quarter strategic framing |
| Bull #5: Capacity expansion + productivity ramp | Strongly Confirmed | 15K AEs; record sales numbers Q4 |
| Bull #6: Margin framework + capital return | Strongly Confirmed | 10+ consecutive quarters OI expansion; $50B buyback |
| Bull #7: Cash flow acceleration | Strongly Confirmed | FY26 OCF/FCF +13-14%; FY27 sustained |
| Bull #8: ITSM TAM expansion | Strongly Confirmed | 180+ customers in 4 months; ServiceNow displacement |
| Bull #9: Life Sciences vs Veeva | Strongly Confirmed | 4+ major pharma displacements disclosed |
| Bull #10: Net New AOV > AOV growth | Sustained | Multi-quarter structural inflection |
| Bull #11: NEW — FY30 framework raise | New Catalyst | $63B from $60B target |
| Bull #12: NEW — $50B buyback authorization | New Catalyst | Major capital return acceleration |
| Bull #13: NEW — Public Sector $5.6B IDIQ | New Catalyst | Multi-year Army revenue framework |
| Bear #1: Modest headline growth | Refuted | +12% nominal / +10% CC Q4 acceleration |
| Bear #2: AI disruption narrative | Refuted | $2.9B AI + Data ARR + customer testimonials |
| Bear #3: Marketing & Commerce weakness | Continuing | Persistent headwind |
Overall: Multi-year compounder thesis strongly validated. 6 of 6 Q3 signposts met. 13 of 13 bull points confirmed or strongly confirmed (including 3 new catalysts). 2 of 3 bear points refuted; only Marketing & Commerce continues. The thesis is operationally validated with strong conviction.
Action: Maintaining Outperform with high conviction. Existing CRM holders: maintain or add aggressively. New positions: $290-320 zone is acceptable entry; bull case 12-month PT $430-470 on continued multi-quarter execution + FY27 framework formalization + AgentForce ARR scaling toward $2B+ + ITSM continued displacement + multi-segment expansion. Next binding catalysts: (1) Q1 FY27 print (late May 2026) — first FY27 quarter validation, (2) Continued ITSM customer expansion + ServiceNow displacement, (3) Life Sciences continued pharma Veeva displacement, (4) Investor Day FY28 (likely September 2026) — multi-year framework refresh, (5) AgentForce ARR scaling toward $1B mid-FY27.